28
Oct
2025

Galileo research srl

Exhibitor at CPHI Frankfurt 2025 stand 6.1F91, Contract Research Organization
About Us

Galileo Research (GR) is an Italian non-clinical CRO established in 2011, GLP and ISO 9001 certified, that provides experience, knowledge and the skills required to take drugs, medical devices, food supplements and cosmetics to the market. GR’s organization flexibility and agility allow us to offer you an extremely customized range of high services (toxicology, biocompatibility, efficacy/performance, mechanisms of action) satisfying all customer non-clinical testing needs. GR’s experience will work side by side with you to successfully reach the Market Place as fast as possible.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • IT
  • 2023
    On CPHI since
  • 2
    Certificates
  • 1 - 24
    Employees
Company types
Contract Research Organisation (CRO)
Primary activities
Contract Research Organisation
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 6.1F91, Contract Research Organization

Products Featured at CPHI Frankfurt 2025

  • Biocompatibility of Medical Devices according to ISO 10993-1 series

    Product Biocompatibility of Medical Devices according to ISO 10993-1 series

    Galileo Research can drive the nonclinical development of your medical device by preparing the Literature Report and the Biological Evaluation Plan (BEP) according to ISO 10993-1, performing additional tests, if needed, and releasing the Biological Evaluation Report (BER).

    All tests can be condu...
  • Consultancy for drug/MD/food development

    Product Consultancy for drug/MD/food development

    Our expertise offered in regulatory submissions and knowledgeable strategic skills in planning non-clinical testing programmes can reduce attrition rate and speed up the process.

  • Drug efficacy, In vitro and in vivo studies

    Product Drug efficacy, In vitro and in vivo studies

    We offer a full range of studies and bioanalytical services, providing powerful tools and rigorous solutions for preclinical drug development of therapeutic candidates, advance lead compounds towards first-in- human trials, and support for ongoing clinical development
  • Drug safety, in vitro and In vivo studies

    Product Drug safety, in vitro and In vivo studies

    In support of human clinical trials and marketing authorization approval, Galileo Research offers a full battery of toxicity studies for the regulatory development of small drugs, as well as biologics and advanced therapies, in compliance with Good Laboratory Practice (GLP), ICH and OECD guidelines.

  • Food safety evaluation

    Product Food safety evaluation

    Potential benefits and safety of dietary supplements need to be assessed by scientifically validated means, in the context of Regulation (EC) 2015/2283 on novel foods. Toxicological data, including genotoxicity, information on absorption, distribution, metabolism and excretion (ADME) need to be collecte...